Showing results (71-80 of 473) with videos related to

Sort By:
Pageof 48
Clinical and Laboratory Haematology|December 21, 2000
A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year periodT T Yee, A Taher, K J Pasi, et al.
American Journal of Hematology|April 3, 2001
Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand diseaseI C Nitu-Whalley, A Griffioen, C Harrington, et al.
British Journal of Haematology|June 1, 1989
Interferon therapy for chronic non-A non-B and chronic delta liver disease in haemophiliaC A Lee, P B Kernoff, P Karayiannis, et al.
British Journal of Haematology|July 1, 1985
High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulinP B Kernoff, C A Lee, P Karayiannis, et al.
Gut|June 1, 1985
Acute fulminant non-A, non-B hepatitis leading to chronic active hepatitis after treatment with cryoprecipitateC A Lee, P B Kernoff, P Karayiannis, et al.
Clinical Orthopaedics and Related Research|November 5, 1997
Orthopaedic surgery in hemophilic patients with human immunodeficiency virusA M Phillips, C A Sabin, W J Ribbans, et al.
British Journal of Haematology|May 1, 1996
Transmission of symptomatic parvovirus B19 infection by clotting factor concentrateT T Yee, B J Cohen, K J Pasi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
The changing patterns of factor VIII (FVIII) and factor IX (FIX) clotting factor usage in a comprehensive care centre between 1980 and 1994A H Miners, C A Sabin, K H Tolley, et al.
Journal of Internal Medicine|January 20, 1999
Assessing the effectiveness and cost-effectiveness of prophylaxis against bleeding in patients with severe haemophilia and severe von Willebrand's diseaseA H Miners, C A Sabin, K H Tolley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 1, 2003
The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia AJ M Lusher, C A Lee, C M Kessler, et al.
Pageof 48